Keywords: new, data, novo, aradigm, inhaled, insulin, nordisk

New data with Novo, Aradigm's inhaled insulin

Article | 26 June 2001

Print This

Novo Nordisk and Aradigm have reported that their inhaled insulinproduct is safe and effective in both smokers and non-smokers, with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in